myeloproliferative diseases
Showing 1 - 9 of 9
Leukemia, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Houston (Fludarabine monophosphate, Busulfan, Stem Cell
Active, not recruiting
- Leukemia
- +9 more
- Fludarabine monophosphate
- +5 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Oct 2, 2020
Myeloproliferative Diseases Trial in Houston (Ruxolitinib, Lenalidomide, Prednisone)
Completed
- Myeloproliferative Diseases
- Ruxolitinib
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jul 8, 2019
Leukemia, Myeloma, Myeloproliferative Diseases Trial in Houston (drug, procedure, behavioral)
Terminated
- Leukemia
- +2 more
- Fludarabine
- +10 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jun 24, 2019
Myeloproliferative Diseases Trial in Houston (Ruxolitinib, Pracinostat, Questionnaire)
Completed
- Myeloproliferative Diseases
- Ruxolitinib
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jun 10, 2019
Myeloproliferative Diseases Trial in Houston (drug, behavioral, procedure)
Terminated
- Myeloproliferative Diseases
- Pacritinib
- +5 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Oct 4, 2018
Leukemia, Myeloproliferative Diseases Trial in Houston (Clofarabine, Cytarabine)
Completed
- Leukemia
- Myeloproliferative Diseases
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jun 5, 2018
Leukemia, Lymphoma, Myeloma Trial in Houston (Fludarabine, Melphalan, Alemtuzumab)
Terminated
- Leukemia
- +3 more
- Fludarabine
- +8 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Feb 18, 2016
Non-Myeloablative Allogeneic Stem Cell Transplantation With
Completed
- Acute Myeloid Leukemia
- +10 more
-
San Francisco, CaliforniaUniversity of California San Francisco
Nov 7, 2012